Market Views
In Recovery
Larger stocks led this week’s comeback with growth stocks picking up the most interest. Our FAANG Index bounced off its low, however I am still expecting a long recovery time for these stocks. For the market as a whole we have a..
Read More
Market Views
Can Go Either Way
Resistance for the QQQ remains between 172.00 and 174.00. Support is between 165.00 and 168.00. A break below 165.00 would imply 162.50 is likely. A break below 162.50 would suggest the low on 10/29 at 160.09 will not hold a..
Read More
The sell-off in this medical diagnostic company is providing a buying opportunity.
Read More
Market Views
Looking for a Sharp Pullback
Predicting exactly when the market will bottom is always a random guessing game at best. I offer no forecast as to when, or at what level, the major averages will hit their final lows. Based on the huge in...
Read More
This healthtech company is expected to grow at 30% annually for the next five years.
Read More
Market Views
It’s the Earnings that Count
History shows that stock prices generally have followed earnings, so it is nice to see actual and projected EPS moving up, even as earnings forecasts often turn out to be too rosy. Happily, the number of companies (79.8%) expectations...
Read More
Market Views
Long-Term Trend Remains Up
The overall market remains in decent shape, with the longer-term trend firmly up, though the intermediate-term trend is a bit iffy. But there remains a ton of rotation and crosscurrents in the market, with many (but not all) growth getting...
Read More
Congrats to the Top Picks 2018, Mid-Year
The markets have seen more volatility in 2018 than last year, with the Dow Jones Industrial Average showing net gains of just 57 points for the year. But the good news is that our contributors have walloped score!
Capturing...
Read More
This largest manufacturer of iron-ore pellets in North America may see renewed interest due to steel tariffs.
Read More
Market Views
Further Gains Likely
Trading was quieter today as investors await the outcome of the Summit. Volatility could pick up as there are announcements this week by the Federal Reserve (FED) and the European Central Bank (ECB) regarding monetary policy where the Fed is to...
Read More
Market Views
Bullish
The Dow successfully tested its lows Thursday and made a bullish tail, and then closed up strongly on Friday. The Dow has been consolidating into a 4-month Head & Shoulders type reversal pattern since late January and we expect it to break through...
Read More
Market Views
Downside will bring Bargains
The market is responding both to the Fed, perhaps more than is realized, as they dismiss the 10-Year behavior and focus only on China. I believe it all matters; and don’t expect catastrophe at the end of the day, the...
Read More
Wall Street expects this gaming company to grow at more than 15% annually, over the next five years.
Read More
Market Views
Volatility Can Be Your Friend
A strong earnings season alongside recent inflation data has supported stock prices. Yet some analysts appear worried about rising inflation and interest rates. The change of tone has increased volatility, which is actually a good thing for investors have...
Read More
Market Views
Volatility Continues
We remain braced for additional downside as the new trading week begins, though we note that the yield on the 10-Year U.S. Treasury ended last week at 2.85%, only a smidge higher than the 2.84% a week earlier. Certainly, interest rates and...
Read More
Congrats to the Top Picks 2017
There aren’t enough superlatives to describe the stock market of 2017. Following the 2016 elections, the markets shot up, with very little down days. The latest estimates of 2017 gains (including dividends) are: Dow Jones Industrial Average (30.199%), 500...
Read More
More than 214,000 shares have been purchased by the insiders of this biotech in the past three months. The shares are trading a very price, reflecting the company’s turnaround status.
Read More
This fund is an opportunity to diversify your biotech holdings. It has a current dividend yield of 8.87%, paid quarterly.
Read More
Market Views
Overbought, But Watch for Short-Term Weakness
The S&P 500 made another all-time high today, but it is overbought. We recently changed parameters for this indicator. Overbought was 70, but now it’s at 80. Note that the last three times it moved above that we...
Read More
Market Views
Still Positive
In the final analysis, while there are definitely a couple of cracks in the stock market’s wall of worry that bear watching in the coming weeks, the weight of technical and fundamental evidence remains positive.
When the bull market has lost its and...
Read More